Literature DB >> 33936429

Automatically classifying the evidence type of drug-drug interaction research papers as a step toward computer supported evidence curation.

Linh Hoang1, Richard D Boyce2, Nigel Bosch1, Britney Stottlemyer2, Mathias Brochhausen3, Jodi Schneider1.   

Abstract

A longstanding issue with knowledge bases that discuss drug-drug interactions (DDIs) is that they are inconsistent with one another. Computerized support might help experts be more objective in assessing DDI evidence. A requirement for such systems is accurate automatic classification of evidence types. In this pilot study, we developed a hierarchical classifier to classify clinical DDI studies into formally defined evidence types. The area under the ROC curve for sub-classifiers in the ensemble ranged from 0.78 to 0.87. The entire system achieved an F1 of 0.83 and 0.63 on two held-out datasets, the latter consisting focused on completely novel drugs from what the system was trained on. The results suggest that it is feasible to accurately automate the classification of a sub-set of DDI evidence types and that the hierarchical approach shows promise. Future work will test more advanced feature engineering techniques while expanding the system to classify a more complex set of evidence types. ©2020 AMIA - All rights reserved.

Year:  2021        PMID: 33936429      PMCID: PMC8075461     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  11 in total

1.  SFINX-a drug-drug interaction database designed for clinical decision support systems.

Authors:  Ylva Böttiger; Kari Laine; Marine L Andersson; Tuomas Korhonen; Björn Molin; Marie-Louise Ovesjö; Tuire Tirkkonen; Anders Rane; Lars L Gustafsson; Birgit Eiermann
Journal:  Eur J Clin Pharmacol       Date:  2009-02-11       Impact factor: 2.953

2.  Turning off frequently overridden drug alerts: limited opportunities for doing it safely.

Authors:  Heleen van der Sijs; Jos Aarts; Teun van Gelder; Marc Berg; Arnold Vulto
Journal:  J Am Med Inform Assoc       Date:  2008-04-24       Impact factor: 4.497

3.  Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.

Authors:  Richard T Scheife; Lisa E Hines; Richard D Boyce; Sophie P Chung; Jeremiah D Momper; Christine D Sommer; Darrell R Abernethy; John R Horn; Stephen J Sklar; Samantha K Wong; Gretchen Jones; Mary L Brown; Amy J Grizzle; Susan Comes; Tricia Lee Wilkins; Clarissa Borst; Michael A Wittie; Daniel C Malone
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

4.  Towards a foundational representation of potential drug-drug interaction knowledge.

Authors:  Mathias Brochhausen; Jodi Schneider; Daniel Malone; Philip E Empey; William R Hogan; Richard D Boyce
Journal:  CEUR Workshop Proc       Date:  2014-10

5.  Implementation pearls from a new guidebook on improving medication use and outcomes with clinical decision support. Effective CDS is essential for addressing healthcare performance improvement imperatives.

Authors:  Anwar M Sirajuddin; Jerome A Osheroff; Dean F Sittig; John Chuo; Ferdinand Velasco; David A Collins
Journal:  J Healthc Inf Manag       Date:  2009

6.  Computing with evidence Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment.

Authors:  Richard Boyce; Carol Collins; John Horn; Ira Kalet
Journal:  J Biomed Inform       Date:  2009-05-10       Impact factor: 6.317

7.  Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support.

Authors:  Kin Wah Fung; Joan Kapusnik-Uner; Jean Cunningham; Stefanie Higby-Baker; Olivier Bodenreider
Journal:  J Am Med Inform Assoc       Date:  2017-07-01       Impact factor: 4.497

Review 8.  Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews.

Authors:  Katrina M Romagnoli; Scott D Nelson; Lisa Hines; Philip Empey; Richard D Boyce; Harry Hochheiser
Journal:  BMC Med Inform Decis Mak       Date:  2017-02-22       Impact factor: 2.796

9.  Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection.

Authors:  Kay Seden; Sara Gibbons; Catia Marzolini; Jonathan M Schapiro; David M Burger; David J Back; Saye H Khoo
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

10.  Testing the face validity and inter-rater agreement of a simple approach to drug-drug interaction evidence assessment.

Authors:  Amy J Grizzle; Lisa E Hines; Daniel C Malone; Olga Kravchenko; Harry Hochheiser; Richard D Boyce
Journal:  J Biomed Inform       Date:  2019-12-12       Impact factor: 6.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.